Effect of passive smoking on the development of chronic obstructive pulmonary disease in southeastern Turkey;Güneydoǧu Anadolu'da kronik obstrüktif akciǧer hastalıgı gelişiminde pasif sigara maruziyetinin etkisi

Turkish Journal of Medical Sciences

Volumn 40, Issue 3, 2010, Pages 349-355

  Yildiz, Tekin ^a   Topçu, Füsun ^a   Çelik, Yusuf ^a   Akyildiz, Levent ^a   Ateş, Güngör ^a   Durak, Dilek ^b  

^a DICLE UNIVERSITY   (Turkey)

^b Adana Devlet Hastanesi   (Turkey)

Author keywords

COPD; Smoking; Spirometry

Indexed keywords

DIAGNOSIS; SMOKE;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COPD; PASSIVE SMOKING; RISK FACTORS; SMOKING; SOUTHEASTERN TURKEY; SPIROMETRY; STUDY SAMPLES;

PULMONARY DISEASES;

SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PATHOGENESIS; QUESTIONNAIRE; RISK FACTOR; SAMPLE SIZE; SMOKING; SPIROMETRY; TURKEY (REPUBLIC);

EID: 77954357256     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-0905-11     Document Type: Article

References (25)

1. Mannino DM, and Holguin Fernando. Epidemiology and global impact of chronic obstructive pulmonary disease. Respiratory Medicine: COPD Update 2006; 1: 114-120.
2. Global strategy for the diagnosis, Management, and prevention of chronic obstructive pulmonary disease Updated 2007. Online available at http//www.goldcopd.org
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349:1498-504.
4. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS et al. Effects of smoking intervention and the use of an inhaled Anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study. JAMA 1994; 272: 1497-505.
5. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates. Chest 2003; 123: 1684-92.
6. Buffels J, Degryse J, Heyrman J, Decramer M. Office spirometry significantly improves early detection of COPD in general practice. The DIDASCO study. Chest 2004; 125: 1394-9.
7. Geijer RMM, Sachs APE, Hoes AW, Salome PL, Lammers J-WJ, Verheij TJ. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Family Practice 2005; 22: 485-9.
8. Lundback B, Lindberg A, Lindstrom M, Rönmark E, Jonsson AC, Jönsson E et al. Not 15 but 50% of smokers develop COPD?-report from the obstructive lung disease in Northern Sweden studies. Respir Med 2003; 97: 115-22.
9. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40-55 years. Br J General Practice 2004; 54: 201-6.
10. Zielinski J and Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119: 731-6.
11. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121: 121S-6S.
12. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002; 51: 1-16.
13. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-20.
14. Minette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms. 1987-updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Respir J 1989; 2: 165-77.
15. Christensen, Ronald. Log-Linear Models & Logistic Regression. Secaucus, NJ, USA: Springer-Verlag New York, 1997: 30. http://www.site.ebrary.com/lib/dicle/Doc?id=10015672&ppg=46
16. American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861-5.
17. Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: S82-4.
18. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977; 115: 195-205.
19. Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL and Buist AS. COPD Prevalence in Salzburg, Austria. Results from the burden of obstructive lung disease (BOLD) study. Chest 2007; 131: 29-36.
20. Nizankowska-Mogilnicka E, Mejza F, Buist AS, Vollmer WM, Skucha W, Harat R et al. Prevalence of COPD and tobacco smoking in Malopolska region-results from the BOLD Study in Poland. Polskie Archiwum Medycyny Wewnetrznej 2007; 117: 402-09.
21. Celik F and Topcu F. Nutritional risk factors for the development of chronic obstructive pulmonary disease (COPD) in male smokers. Clinical Nutrition 2006; 25: 955-961.
22. Lamprecht B, Schirnhofer L, Kaiser B, Studnicka M, and Buist AS. Farming and the prevalence of non-reversible Airways obstruction-results from a Population-based study American Journal of Industrial Medicine 2007; 50: 421-426.
23. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, and Pehlivan E. Prevalence of COPD: First epidemiological study of a large region in Turkey. European Journal of Internal Medicine 2008; 19: 499-504.
24. Buist AS, Vollmer WM, and McBurnie MA. Worldwide burden of COPD in high-and low-income countries. Part I. The Burden of Obstructive Lung Disease (BOLD) Initiative. Int J Tuberc Lung Dis 2008; 12: 595-600.
25. Mohammad Y, Kakah M and Mohammad Y. Chronic respiratory effect of narguileh smoking compared with cigarette smoking in women from the East Mediterranean region. International Journal of COPD 2008: 3; 405-414.